News Highlights

Check this page for recent news from Appili Therapeutics.

Members of the media can contact us here, or for general inquiries, contact us here.

October 29, 2020
Appili Therapeutics Appoints Drug Development Executive Don Cilla to the Newly Created Position of Chief Development Officer
October 27, 2020
Appili Therapeutics to Present at TSX Life Sciences Investor Day
October 27, 2020
Appili Therapeutics Announces Additional Funding for Its ATI-1701 Biodefense Program
October 20, 2020
First Participants Dosed in Appili Therapeutics’ Phase 2 Clinical Trial Evaluating Favipiravir for COVID-19 Outbreak Control in Canadian Long-Term Care Homes
September 14, 2020
Appili Therapeutics to Commence Trading on Main Board of the TSX Exchange